title: Maintaining immunosuppressive treatment after early allograft nephrectomy does not reduce the risk of anti-HLA allosensitization.
authors: Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France. delbello.a@chu-toulouse.fr.|Université Paul Sabatier, Toulouse, France. delbello.a@chu-toulouse.fr.
authors: Arnaud
authors: A
authors: Del Bello
authors: Université Paul Sabatier, Toulouse, France.|Molecular Immunogenetics Laboratory, Faculté de Médecine Purpan, EA 3034, IFR150 (INSERM), Toulouse, France.|Department of Immunology, CHU Toulouse, Toulouse, France.
authors: Nicolas
authors: N
authors: Congy-Jolivet
authors: Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.|Université Paul Sabatier, Toulouse, France.|INSERM U1043, IFR-BMT, CHU Purpan, Toulouse, France.
authors: Nassim
authors: N
authors: Kamar
mesh_terms: D064591:Allografts; D000906:Antibodies / Q000737:chemistry; D003165:Complement System Proteins / Q000276:immunology; D006084:Graft Rejection; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000379:methods*; D009392:Nephrectomy / Q000379:methods*; D051437:Renal Insufficiency / Q000276:immunology / Q000601:surgery
chemical_list: D000906:Antibodies; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D003165:Complement System Proteins